174 related articles for article (PubMed ID: 16221732)
41. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
RosanĂ² L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
[TBL] [Abstract][Full Text] [Related]
42. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
44. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
[TBL] [Abstract][Full Text] [Related]
45. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
46. Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells.
Yoshida C; Niiya K; Niiya M; Shibakura M; Asaumi N; Tanimoto M
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):425-33. PubMed ID: 17581316
[TBL] [Abstract][Full Text] [Related]
47. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
48. Expression of CTGF and Cyr61 in colorectal cancer.
Ladwa R; Pringle H; Kumar R; West K
J Clin Pathol; 2011 Jan; 64(1):58-64. PubMed ID: 21081514
[TBL] [Abstract][Full Text] [Related]
49. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract][Full Text] [Related]
50. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.
Schlechte W; Brattain M; Boyd D
Cancer Commun; 1990; 2(5):173-9. PubMed ID: 2164413
[TBL] [Abstract][Full Text] [Related]
51. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
52. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
53. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
[TBL] [Abstract][Full Text] [Related]
54. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
[TBL] [Abstract][Full Text] [Related]
55. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
[TBL] [Abstract][Full Text] [Related]
57. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
[TBL] [Abstract][Full Text] [Related]
58. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases.
Kondo S; Kubota S; Shimo T; Nishida T; Yosimichi G; Eguchi T; Sugahara T; Takigawa M
Carcinogenesis; 2002 May; 23(5):769-76. PubMed ID: 12016149
[TBL] [Abstract][Full Text] [Related]
59. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.
Sternlicht MD; Dunning AM; Moore DH; Pharoah PD; Ginzinger DG; Chin K; Gray JW; Waldman FM; Ponder BA; Werb Z
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2107-14. PubMed ID: 17119035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]